Nicotine Pouch Unit Sales in the US From 2016 to 2020

CDC has released the following tobacco-related publication in the journal, JAMA.

Nicotine Pouch Unit Sales in the US from 2016 to 2020

Manufacturers are currently marketing nicotine pouches and e-cigarettes with synthetic nicotine in the US.  Whether derived from tobacco plants or synthetically developed in a laboratory, nicotine is an addictive drug with known adverse consequences for fetal development and adolescent brain development.

Given public health considerations, synthetic nicotine products warrant urgent attention from policy makers, clinicians, and researchers.  Sufficient scientific evidence about nicotine’s harmful effects exists to caution young people and pregnant adults against use of synthetic nicotine and to justify inclusion of synthetic nicotine products in existing regulatory efforts.

The article is available online at:
https://jamanetwork.com/journals/jama/fullarticle/2787119

×

Upcoming Events

Attending any of these upcoming events? Have other events to share? Let us know! Email us at NNN@ITCMI.ORG to share your event information or to get on our list serve for event updates.

 

National Conference on Tobacco or Health (NCTOH) is now accepting abstracts! Deadline November 15, 2024 | LEARN MORE

FUNDING OPPORTUNITY | California Department of Public Health - Due November 21, 2024 | LEARN MORE AND APPLY

WEBINAR:  Pediatric, Adolescent, and Young Adult Cancer Survivorship ECHO from American Cancer Society | LEARN MORE AND REGISTER

2025 NACCHO 360 Annual Conference; Anaheim, CA | SAVE THE DATE | LEARN MORE

2025 National Conference on Tobacco or Health | SAVE THE DATE | LEARN MORE

2025 National Conference on Tobacco or Health; presented by National Network of Public Health Institutes; Chicago, Illinois | LEARN MORE AND REGISTER